Last updated on June 2019

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Brief description of study

The purpose of this study is to assess the efficacy and safety of ruxolitinib cream in adolescents and adults with atopic dermatitis (AD).

Clinical Study Identifier: NCT03745651

Find a site near you

Start Over

Well Pharma Medical Research Corporation

South Miami, FL United States
  Connect »